During the past decade, Anchorage Oncology Centre conducted 124 clinical trials. In the 10-year time frame, 124 clinical trials started and 67 clinical trials were completed, i.e. on average, 54% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 46 clinical trials were completed. i.e. 131.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Anchorage Oncology Centre" #1 sponsor was "National Cancer Institute (NCI)" with 89 trials, followed by "Alliance for Clinical Trials in Oncology" with 36 trials sponsored, "SWOG Cancer Research Network" with 34 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "Gynecologic Oncology Group" with 16 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Anchorage Oncology Centre" #1 collaborator was "National Cancer Institute (NCI)" with 104 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Celgene Corporation" with 2 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Anchorage Oncology Centre" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Invasive Breast Carcinoma" (8 trials), "Recurrent Ovarian Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "Anchorage Oncology Centre" in a lesser frequency.

Most popular intervention types in "Anchorage Oncology Centre" are "Drug" (158 trials), "Other" (114 trials), "Biological" (86 trials), "Procedure" (54 trials) and "Radiation" (27 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (57 trials), "Quality-of-Life Assessment" (45 trials), "Computed Tomography" (30 trials), "Biospecimen Collection" (29 trials) and "Questionnaire Administration" (29 trials). Other intervention names were less common.

The vast majority of trials in "Anchorage Oncology Centre" are 161 trials for "All" genders, 31 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Anchorage Oncology Centre". undefined are not yet recruiting, 61 are recruiting, 91 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Anchorage Oncology Centre, 5 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Anchorage Oncology Centre, 6 "Phase 1" clinical trials were conducted, 104 "Phase 2" clinical trials and 92 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".